This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Dec 8;128(23):2595-2597.

doi: 10.1182/blood-2016-10-743930.

Ticagrelor: agonising over its mechanisms of action

William A E Parker¹, Robert F Storey¹

Affiliations

PMID: 27932327
DOI: 10.1182/blood-2016-10-743930

Free article

Comment

Ticagrelor: agonising over its mechanisms of action

William A E Parker et al. Blood. 2016.

Free article

. 2016 Dec 8;128(23):2595-2597.

doi: 10.1182/blood-2016-10-743930.

Authors

William A E Parker¹, Robert F Storey¹

Affiliation

¹ UNIVERSITY OF SHEFFIELD.

PMID: 27932327
DOI: 10.1182/blood-2016-10-743930

No abstract available

PubMed Disclaimer

Comment on

Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.
Aungraheeta R, Conibear A, Butler M, Kelly E, Nylander S, Mumford A, Mundell SJ. Aungraheeta R, et al. Blood. 2016 Dec 8;128(23):2717-2728. doi: 10.1182/blood-2016-03-707844. Epub 2016 Sep 30. Blood. 2016. PMID: 27694321 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations